Financhill
Back

Cytokinetics Stock Predictions

Cytokinetics Stock Forecast

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 4.4% based on the past 21 years of stock performance.
  • Cytokinetics has risen higher in 11 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.38%
  • Is Cytokinetics Stock Undervalued?
    The current Cytokinetics [CYTK] share price is $32.30. The Score for CYTK is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Cytokinetics Stock Go Up Next Year?

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 4.4% based on the past 21 years of stock performance.

Cytokinetics Stock Rating

Sell
28
Cytokinetics (CYTK) is a Sell

Is Cytokinetics overpriced?

  • Cytokinetics has risen higher in 11 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.38%

Cytokinetics Stock Price History

Is CYTK stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYTK is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com

52-Week Data

52-Week High:
61.38
52-Week Low:
29.31

Prediction Charts

Market Cap:
3.9B
Price in USD:
32.30
Volume:
768.3K
Beta:
1.41

Technical Analysis

SMA50:
35.68
SMA100:
40.80
SMA200:
46.80
52-Wk Change:
-38.22%

Stock Predictions

  • Is Cytokinetics stock public?
    Yes, Cytokinetics is a publicly traded company.
  • What is the Cytokinetics stock quote today?
    The Cytokinetics stock price is 32.30 USD today.
  • How to buy Cytokinetics stock online?
    You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-19 30.64 30.75 31.41 30.23
May-20 30.83 32.66 33.04 30.59
May-21 32.41 31.31 32.75 30.98
May-22 31.16 30.49 31.26 30.46
May-23 29.94 30.54 30.64 29.83
May-27 31.27 30.53 31.27 29.81
May-28 30.57 30.28 31.02 30.21
May-29 30.23 31.32 31.36 30.02
May-30 31.41 31.02 31.42 30.26
Jun-2 31.11 31.21 32.14 30.55
Jun-3 31.16 32.00 32.26 30.81
Jun-4 32.07 32.41 32.75 32.02
Jun-5 32.16 32.08 32.33 31.52
Jun-6 32.28 32.30 32.80 32.14

Cytokinetics Earnings

Cytokinetics Earnings Report: Per Share Cytokinetics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cytokinetics Forecast Revenue Growth

Cytokinetics Stock Analysis: Historical quarterly revenues per share for Cytokinetics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.59 per share, a decrease this year of $0.31 per share, and an increase next year of $0.46 per share.

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.